Review your assessment of anxiety symptoms, diagnosis of anxiety disorders and selection of evidence-based treatment options.
This Clinical e-Audit requires data to be submitted for SEVEN (7) patients.
Anxiety: rethinking the options
Focuses on assessment of anxiety disorders and evidence-based approaches to management. Both psychological and pharmacological treatment options will be discussed
Low back pain: taking action
Confidently recognise when low back pain requires further investigation and identify patients at risk of chronic, disabling pain.
Type 2 diabetes and CVD: managing the risk
Improve health outcomes for your patients with both type 2 diabetes and cardiovascular disease (CVD) by familiarising yourself with the latest CV outcome data and increasing your confidence to navigate management choices for these patients.
PPIs in GORD: a stepped approach
Review your proton pump inhibitor (PPI) prescribing for patients with gastro-oesophageal reflux disease (GORD) and be guided on implementing an effective step-down approach for your patients.
PPIs: reviewing treatment for gastro-oesophageal reflux disease
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?
Taking action for acute low back pain
Kyle, a 47-year-old man, presents with a history of low back pain for 8 days. He wants to know if he has damaged his back and is requesting imaging. What now?
COPD: a stepwise approach
Use a stepwise approach to manage patients with chronic obstructive pulmonary disease (COPD) and individualise choice of inhaler based on patient-specific factors.
This Clinical e-Audit requires data to be submitted for only SEVEN (7) patients.
Neuropathic pain: a roadmap for diagnosis and management
Improve patient outcomes by using a stepwise approach to diagnosing neuropathic pain, and discover emerging evidence for first-line medicines.
Due to the low prevalence of neuropathic pain, this Clinical e-Audit requires data to be submitted for only FIVE (5) patients.